4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001209191-14-075866
CIK 0001333170operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:26 PM ET
Size
10.0 KB
Accession
0001209191-14-075866
Insider Transaction Report
Form 4
Hershberger Kevin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2014-12-12$9.96/sh+5,000$49,800→ 26,485 total - Sale
Common Stock
2014-12-15$17.45/sh−3,000$52,350→ 18,485 total - Sale
Common Stock
2014-12-12$17.04/sh−5,000$85,200→ 21,485 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-12−5,000→ 7,576 totalExercise: $9.96From: 2010-04-03Exp: 2017-03-02→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:26 PM ET
- Size
- 10.0 KB